Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) kicked off on Friday, up 0.29% from the previous trading day, before settling in for the closing price of $41.14. Over the past 52 weeks, ARWR has traded in a range of $9.57-$43.69.
While this was happening, its average annual earnings per share was recorded 102.18%. With a float of $129.23 million, this company’s outstanding shares have now reached $138.14 million.
Arrowhead Pharmaceuticals Inc (ARWR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Arrowhead Pharmaceuticals Inc is 6.53%, while institutional ownership is 79.54%. The most recent insider transaction that took place on Oct 01 ’25, was worth 700,000. In this transaction Chief Medical Officer of this company sold 20,000 shares at a rate of $35.00, taking the stock ownership to the 212,122 shares. Before that another transaction happened on Oct 01 ’25, when Company’s Officer proposed sale 20,000 for $35.00, making the entire transaction worth $700,015.
Arrowhead Pharmaceuticals Inc (ARWR) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.37 earnings per share (EPS), lower than consensus estimate (set at -0.92) by -0.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.33 per share during the current fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Take a look at Arrowhead Pharmaceuticals Inc’s (ARWR) current performance indicators. Last quarter, stock had a quick ratio of 4.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.26, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -2.95 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.64 million. That was inferior than the volume of 2.03 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 65.29%.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 91.73%, which indicates a significant increase from 61.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.30 in the past 14 days, which was higher than the 1.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.85, while its 200-day Moving Average is $21.42. However, in the short run, Arrowhead Pharmaceuticals Inc’s stock first resistance to watch stands at $42.25. Second resistance stands at $43.25. The third major resistance level sits at $44.71. If the price goes on to break the first support level at $39.80, it is likely to go to the next support level at $38.34. Assuming the price breaks the second support level, the third support level stands at $37.34.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Key Stats
The company with the Market Capitalisation of 5.70 billion has total of 138,258K Shares Outstanding. Its annual sales at the moment are 3,550 K in contrast with the sum of -599,490 K annual income. Company’s last quarter sales were recorded 27,770 K and last quarter income was -175,240 K.
